Lymphatic Drainage Therapy for Sleep Apnea

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether improving lymphatic drainage, the body's waste removal system, can aid individuals with obstructive sleep apnea (OSA) by enhancing brain fluid clearance. Participants will use a device called Neuroglide for nightly automated manual lymphatic drainage therapy and undergo at-home sleep monitoring. It is best suited for individuals aged 50 and older who have OSA and have consistently used a CPAP machine for at least six months. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance sleep apnea treatment.

Will I have to stop taking my current medications?

The trial requires that you stay on your current medication regimen for at least 3 months and not plan to change it during the study.

What prior data suggests that this therapy is safe for patients with sleep apnea?

Research has shown that Automated Manual Lymphatic Drainage Therapy (AMLDT) is generally safe. In one study, patients who tried AMLDT did not experience any problems. Those with pre-treatment pain reported less pain afterward, suggesting the therapy is well-tolerated.

While researchers continue to study this therapy for sleep apnea, its use in other conditions indicates it could be safe. Prospective trial participants might find this information reassuring regarding the therapy's safety.12345

Why are researchers excited about this trial?

Researchers are excited about Automated Manual Lymphatic Drainage Therapy for sleep apnea because it offers a novel, non-invasive approach to managing the condition. Unlike traditional treatments like CPAP machines or oral appliances that focus on keeping the airway open, this therapy aims to enhance lymphatic drainage, potentially reducing inflammation and improving airway function naturally. This could provide a more comfortable and accessible option for patients who struggle with or prefer to avoid conventional treatments.

What evidence suggests that Automated Manual Lymphatic Drainage Therapy is effective for obstructive sleep apnea?

Research has shown that manual lymphatic drainage therapy might improve sleep quality. A review found that this therapy led to better sleep in several studies. This is promising for people with obstructive sleep apnea (OSA), as better sleep could help manage their condition. The therapy improves lymph flow, which is believed to support brain function and may enhance sleep. Although specific data on this therapy for OSA is limited, its benefits for sleep in other contexts are encouraging. Participants in this trial will receive Automated Manual Lymphatic Drainage Therapy to evaluate its effectiveness specifically for OSA.14567

Who Is on the Research Team?

DZ

Diego Zaquera Carvalho, M.D., M.S.

Principal Investigator

Mayo Clinic

Are You a Good Fit for This Trial?

This trial is for people aged 50 or older with obstructive sleep apnea who have been using CPAP therapy successfully and consistently for at least 6 months. Participants must be willing to use an automated lymphatic drainage device nightly for a month and do home sleep monitoring. They should also be on stable medication regimens for other health issues.

Inclusion Criteria

My current medication for other health issues has been stable for 3 months.
I have been using CPAP therapy consistently for at least 6 months.
I am willing to use a lymphatic drainage device and monitor my sleep at home for a month.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo nightly Automated Manual Lymphatic Drainage Therapy (AMLDT) for one month

4 weeks
Home-based intervention with ambulatory sleep tracking

Follow-up

Participants are monitored for changes in sleep architecture and serum biomarkers

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Automated Manual Lymphatic Drainage Therapy

Trial Overview

The study tests if an Automated Manual Lymphatic Drainage Therapy (AMLDT) device, used nightly, can improve the brain's waste clearance system in patients with obstructive sleep apnea. The research aims to see if better lymphatic drainage leads to improved brain function.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: InterventionExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+

Citations

Automated Manual Lymphatic Drainage Therapy to ...

The purpose of this research is to investigate whether enhancing systemic lymphatic drainage improves glymphatic function in patients with ...

HSD99 Evaluating the Efficiency of an Automated Pathway ...

Results: The use of digital health ser- vices reduces waiting time for clinic services by 1.81% and for laboratory tests by. 3.38%. However, using digital ...

Systematic Review of Efficacy for Manual Lymphatic ...

The following data were extracted from selected publications to assess the efficacy and effectiveness of MLDTs in sports medicine and rehabilitation as well as ...

Artificial intelligence in sleep medicine: background and ...

The most obvious application of ML in sleep medicine to improve clinical efficiency is automated PSG sleep staging, but many other manual clinical activities ...

Effect of Cervical Manual Therapy on Sleep Quality

Among them, seven RCTs (70.0%) reported significant improvements in sleep quality that were not dependent on alleviating the primary diseases, with notable ...

The effect of automated manual lymphatic drainage ...

Results. All 4 cases completed the NIRFLI and AMLDT without complications; all 3 patients with baseline pain reported reduced pain posttreatment ...

Lymphatic Drainage Therapy for Sleep Apnea

The study tests if an Automated Manual Lymphatic Drainage Therapy (AMLDT) device, used nightly, can improve the brain's waste clearance system in patients with ...